Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer

Zemin Hou1, Shengsong Huang2, Zejie Mei1

  • 1State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China.

Insights

Prostate cancer progression is linked to progesterone, not just androgens. Inhibiting progesterone production may offer new therapeutic strategies for patients, as elevated levels indicate poor outcomes.

Area of Science:

  • Endocrinology
  • Oncology
  • Metabolomics

Background:

  • Prostate cancer growth is typically linked to androgens.
  • The progression of prostate cancer after androgen deprivation suggests other contributing factors, termed oncometabolites.
  • The role of progesterone in prostate cancer has not been fully elucidated.

Purpose of the Study:

  • To investigate the potential oncogenic effects of progesterone in prostate cancer.
  • To identify therapeutic strategies targeting progesterone production or action.

Main Methods:

  • Mass-spectrometry-based screening of clinical specimens.
  • Retrospective analysis of clinical data from prostate cancer patients.
  • Investigated the effects of progesterone on androgen receptor (AR) target genes and cell proliferation via GATA2.

Main Results:

  • Progesterone, at high doses, activates both canonical and non-canonical AR target genes.
  • Physiological levels of progesterone promote cell proliferation through GATA2.
  • Inhibitors of 3β-hydroxysteroid dehydrogenase 1 (3βHSD1) were found to suppress progesterone generation.
  • Increased progesterone levels correlate with poorer clinical outcomes and may serve as a predictive biomarker.

Conclusions:

  • Progesterone acts as an oncogenic hormone in prostate cancer.
  • Targeting progesterone generation or its effects presents a potential therapeutic avenue for prostate cancer patients.
  • Progesterone may be a useful predictive biomarker for prostate cancer prognosis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.3K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.6K